Taiwan Advance Bio-Pharmaceutical Inc.
4186
Rank in Stocks
#26683
Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a... Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a substantial international presence, conducting operations across numerous countries such as China, Germany, the USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, and Pakistan, in addition to other global markets. Founded in 1989 and headquartered in New Taipei City, Taiwan, the company delivers a comprehensive array of products and services. Its offerings encompass diagnostic kits for ensuring food safety, alongside tailored customization services for ELISA, rapid, and chemical test kits, and expert consultation for setting up food safety laboratories. The firm also specializes in manufacturing both monoclonal and polyclonal antibody products. Furthermore, its portfolio includes rapid screening tests for illicit substances. It provides essential cell banking services for the secure preservation of both newborn and adult stem cells. The company also operates a dedicated drug testing facility, performing analyses on urine and hair samples to detect and identify drug abuse.
Share Price
$0.21095245
Last synced: 2026-11-10
Market Cap
$18.99M
Change (1 day)
0.29%
Change (1 year)
-49.32%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Taiwan Advance Bio-Pharmaceutical Inc. (4186)
Category
Healthcare
Operating Margin for Taiwan Advance Bio-Pharmaceutical Inc. (4186)
Operating Margin as of November 2026 TTM: 5.28%
According to Taiwan Advance Bio-Pharmaceutical Inc.'s latest financial reports, its current operating margin (TTM) is 5.28%. At the end of 2025 the company had an operating margin of 7.95%.
Operating Margin history for Taiwan Advance Bio-Pharmaceutical Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 5.28% | -33.58% |
| 2025 | 7.95% | -37.20% |
| 2024 | 12.66% | 837.78% |
| 2023 | 1.35% | -43.51% |
| 2022 | 2.39% | -105.66% |
| 2021 | -42.25% | 9.68% |
| 2020 | -38.52% | -48.84% |
| 2019 | -75.30% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -92.69% |
US
|
|
| -149.01% | -128.22% |
US
|
|
| 25.57% | -95.16% |
AU
|
|
| 31.23% | -94.09% |
BE
|
|
| 29.35% | -94.44% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Taiwan Advance Bio-Pharmaceutical Inc.'s operating margin
What is Taiwan Advance Bio-Pharmaceutical Inc.'s operating margin?
Taiwan Advance Bio-Pharmaceutical Inc.'s operating margin is 5.28%, as of Nov 2026.
What was Taiwan Advance Bio-Pharmaceutical Inc.'s operating margin in 2025?
In 2025, Taiwan Advance Bio-Pharmaceutical Inc.'s operating margin was 7.95%, compared with 12.66% in 2024.
How has Taiwan Advance Bio-Pharmaceutical Inc.'s operating margin changed since 2020?
From 2020 to 2025, Taiwan Advance Bio-Pharmaceutical Inc.'s operating margin was highest in 2024 (12.66%) and lowest in 2021 (-42.25%).
How does Taiwan Advance Bio-Pharmaceutical Inc.'s operating margin compare with similar companies?
Taiwan Advance Bio-Pharmaceutical Inc.'s operating margin (5.28%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.